Endüstriler
Showing all 2 results
-
Revenue Cycle Management (RCM) Market in United States 2022
Revenue Cycle Management (RCM) refers to the process of identifying, collecting and managing the practice’s revenue from payers based on the services provided. A successful RCM process is essential for a healthcare practice to maintain financial viability and continue to provide quality care for its patients. A study by StrategyHelix indicates that the revenue cycle management market in United States is expected to increase by US$ 33,743 milyon itibaren 2022 ile 2028, garnering a CAGR of 15.9% tahmin dönemi boyunca. Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the revenue cycle management market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.
-
Liquid Biopsy Market in United States 2022
A liquid biopsy is a simple and non-invasive alternative to surgical biopsies which enables doctors to discover a range of information about a tumour through a simple blood sample. Traces of the cancer’s DNA in the blood can give clues about which treatments are most likely to work for that patient. StratejiHelix'e göre, the liquid biopsy market in United States is expected to increase by US$ 3.80 sırasında milyar 2022-2028, expanding at a CAGR of 11.7% tahmin dönemi boyunca. Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the liquid biopsy market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.